Lung cancer doesn’t just come from smoking. The amount of ultraprocessed food a person eats and drinks could be connected ...

With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer ...

TEM expands its AI-driven Tempus Next platform into breast cancer, targeting key testing gaps to improve care delivery.

Phase III data show Hernexeos can elicit a confirmed objective response rate of 48% in patients with HER2-mutated NSCLC who had previously been treated with a directed antibody-drug conjugate.

New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer ...

In honor of World Lung Cancer Day on Aug. 1, Olympus Corp. of the Americas (OCA), a global medical technology company ...

A group of Australian scientists has uncovered a new way to fight some of the toughest cancers by targeting an overlooked ...

A new study suggests that an increased risk of lung cancer may be linked to consumption of ultraprocessed foods.

A study by Tianjin First Central Hospital researchers reveals the miR-451/ETV4/MMP13 signaling axis as a critical regulator of NSCLC progression. Findings show miR-451 suppression activates ETV4-MMP13 ...

The University of Pittsburgh and UPMC Hillman Cancer Center have released new research suggesting that using sucralose — a ...

New therapies harness the body’s cancer-fighting powers, but they don't work for everyone. UChicago experts aim to change ...